{
    "clinical_study": {
        "@rank": "149671", 
        "arm_group": [
            {
                "arm_group_label": "Dexmedetomidine", 
                "arm_group_type": "Experimental", 
                "description": "dexmedetomidine/precedex"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "patients receive saline solution."
            }
        ], 
        "brief_summary": {
            "textblock": "This study is trying to see if using precedex pre-operatively prevents emergence delirium in\n      pediatric (ages 1-7) patients undergoing strabismus surgery."
        }, 
        "brief_title": "Efficacy of Single-Shot Dexmedetomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Strabismus", 
            "Delirium on Emergence", 
            "Pediatric Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Delirium", 
                "Strabismus"
            ]
        }, 
        "detailed_description": {
            "textblock": "Emergence delirium (ED) is a complex behavioral disturbance characterized by psychomotor\n      agitation, perceptual disturbances, delusions, and disorientation during recovery from\n      general anesthesia. In the population of subjects who undergo strabismus surgery, there are\n      multiple factors that may increase the risk of ED. These include age, typically preschool\n      children aged 1-7 years, rapid surgical times with rapid awakening, use of sevoflurane as\n      the primary anesthetic, and surgically-induced postoperative visual disturbance. The aims of\n      this study are: 1) To examine whether post-induction treatment with an \u03b1-2 receptor agonist,\n      precedex (dexmedetomidine), decreases postoperative emergence agitation after strabismus\n      surgery compared to placebo, and 2) to determine whether treatment has any effect on\n      postoperative pain, nausea/vomiting, number of pain-related interventions, and time to PACU\n      discharge. We hypothesize that precedex  will attenuate the ED response greater than placebo\n      or a lower dose after strabismus surgery and will reduce PACU pain scores without increasing\n      PACU length of stay.\n\n      Inclusion:\n\n      i. Pediatric patients aged 1-7 years of age ii. ASA physical status I-II iii. No significant\n      laboratory abnormalities\n\n      Exclusion:\n\n      i. Presence of medicated behavioral disorder ii. Subjects for which precedex, opiates,\n      benzodiazepines, or inhalational anesthetics are contraindicated iii. Parental refusal"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ASA physical status of I or II\n\n          -  male or female, aged 1-7\n\n          -  has no significant lab abnormalities\n\n        Exclusion Criteria:\n\n          -  ASA physical status of III, IV or V\n\n          -  Presence of medicated behavioral disorder\n\n          -  Subjects for which dexmedetomidine, opiates, benzodiazepines or inhalational\n             anesthetics are contraindicated.\n\n          -  Parental refusal"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "7 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "132", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01901588", 
            "org_study_id": "S12-00556"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dexmedetomidine", 
                "description": "intravenous dose of dexmedetomidine 0.3 mcg/kg over 5 minutes", 
                "intervention_name": "Dexmedetomidine", 
                "intervention_type": "Drug", 
                "other_name": "Precedex"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "intraoperative dose of intravenous placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other", 
                "other_name": "saline solution"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Dexmedetomidine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "strabismus", 
            "pediatric", 
            "emergence delirium", 
            "precedex/dexmedetomidine"
        ], 
        "lastchanged_date": "March 26, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10016"
                }, 
                "name": "NYU Langone Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Jason Brown, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Gordana Stjepanovic, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Mark Steele, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jennifer McGrath, BA, MS", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Lola Franco, BA", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Annelise E von Bergen Granell, BS, MS", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Avri Bohm, BA", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Sorosch Didehvar, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Manit Roy, BS", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Michael Haile, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Wanda Chin, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy of Single-Shot Dexmedetomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery", 
        "overall_contact": {
            "email": "lola.franco@nyumc.org", 
            "last_name": "Lola Franco, BA", 
            "phone": "212.263.0531"
        }, 
        "overall_contact_backup": {
            "email": "annelise.vonbergengranell@nyumc.org", 
            "last_name": "Annelise E von Bergen Granell, BS, MS", 
            "phone": "212.263.0667"
        }, 
        "overall_official": {
            "affiliation": "NYU School of Medicine", 
            "last_name": "Jason Brown, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To examine whether post-induction treatment with an \u03b1-2 receptor agonist, dexmedetomidine, decreases postoperative emergence agitation after strabismus surgery compared to placebo", 
            "measure": "Efficacy of Single-Shot Dexmedetomidine versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery", 
            "safety_issue": "No", 
            "time_frame": "two years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01901588"
        }, 
        "responsible_party": {
            "investigator_affiliation": "New York University School of Medicine", 
            "investigator_full_name": "Wanda Chin", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "to determine whether treatment has any effect on postoperative pain, nausea/vomiting, number of pain-related interventions, and time to PACU discharge", 
            "measure": "Post operative interventions", 
            "safety_issue": "No", 
            "time_frame": "4 hours after surgery"
        }, 
        "source": "New York University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "New York University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}